Skip to Content

Avelumab Maintenance Is a Standard of Care Option for Patients with Advanced Urothelial Carcinoma

Long-term follow-up data suggests that avelumab maintenance is a standard of care option for patients who already achieved stable disease or response after platinum-based chemotherapy, with no new safety concerns. Petros Grivas from University of Washington Medicine & Fred Hutchinson Cancer Center, USA, elaborates on the JAVELIN Bladder 100 Trial in this MEDtalk from ESMO 2024.

Petros Grivas

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top